IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women

Publication Date:
2018-05-19
Publisher:
MDPI Publishing
Print ISSN:
1661-7827
Electronic ISSN:
1660-4601
Topics:
Energy, Environment Protection, Nuclear Power Engineering
Medicine
Published by:
http://www.mdpi.com/
_version_ 1836398934921052160
autor Jerilynn C. Prior; Chiaki Konishi; Christine L. Hitchcock; Elaine Kingwell; Patti Janssen; Anthony P. Cheung; Nichole Fairbrother; Azita Goshtasebi
beschreibung IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women International Journal of Environmental Research and Public Health doi: 10.3390/ijerph15051016 Authors: Jerilynn C. Prior Chiaki Konishi Christine L. Hitchcock Elaine Kingwell Patti Janssen Anthony P. Cheung Nichole Fairbrother Azita Goshtasebi Approximately 33% of normal-length (21–35 days) cycles have subclinical ovulatory disturbances and lack sufficient progesterone, although their normal length ensures enough estrogen. Subclinical ovulatory disturbances are related to significant premenopausal spine bone loss (−0.86%/year). Molimina, non-distressing premenstrual experiences, may detect ovulation within normal-length cycles. This prospective study assessed the relationship between molimina and ovulation. After 1-cycle of daily diary and first morning urine collections, women answered the Molimina Question (MQ): “Can you tell by the way you feel that your period is coming?” and were invited to share (a) predictive premenstrual experience(s). A 3-fold increase in follicular-luteal pregnanediol levels confirmed ovulation. In 610 spontaneously menstruating women (not on hormonal contraception, mean age 31.5 ± 5.3, menarche age 12.7 ± 1.5, cycle length [CL] 29 days, MQ positive in 89%), reported premenstrual experiences which included negative moods (62%), cramps (48%), bloating (39%), and front (26%) or axillary (25%) breast tenderness. Of 432 women with pregnanediol-documented cycles, 398 (92%) were ovulatory (CL: 29 ± 5) and 34 (8%) had ovulatory disturbances (CL: 32 ± 14). Women with/without ovulatory cycles were similar in parity, body mass index, smoking, dietary restraint and the MQ; ovulatory-disturbed cycles were longer. Molimina did not confirm ovulation. A non-invasive, inexpensive ovulation indicator is needed to prevent osteoporosis.
citation_standardnr 6262114
datenlieferant ipn_articles
feed_id 52459
feed_publisher MDPI Publishing
feed_publisher_url http://www.mdpi.com/
insertion_date 2018-05-19
journaleissn 1660-4601
journalissn 1661-7827
publikationsjahr_anzeige 2018
publikationsjahr_facette 2018
publikationsjahr_intervall 7984:2015-2019
publikationsjahr_sort 2018
publisher MDPI Publishing
quelle International Journal of Environmental Research and Public Health
relation http://www.mdpi.com/1660-4601/15/5/1016
search_space articles
shingle_author_1 Jerilynn C. Prior; Chiaki Konishi; Christine L. Hitchcock; Elaine Kingwell; Patti Janssen; Anthony P. Cheung; Nichole Fairbrother; Azita Goshtasebi
shingle_author_2 Jerilynn C. Prior; Chiaki Konishi; Christine L. Hitchcock; Elaine Kingwell; Patti Janssen; Anthony P. Cheung; Nichole Fairbrother; Azita Goshtasebi
shingle_author_3 Jerilynn C. Prior; Chiaki Konishi; Christine L. Hitchcock; Elaine Kingwell; Patti Janssen; Anthony P. Cheung; Nichole Fairbrother; Azita Goshtasebi
shingle_author_4 Jerilynn C. Prior; Chiaki Konishi; Christine L. Hitchcock; Elaine Kingwell; Patti Janssen; Anthony P. Cheung; Nichole Fairbrother; Azita Goshtasebi
shingle_catch_all_1 IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women International Journal of Environmental Research and Public Health doi: 10.3390/ijerph15051016 Authors: Jerilynn C. Prior Chiaki Konishi Christine L. Hitchcock Elaine Kingwell Patti Janssen Anthony P. Cheung Nichole Fairbrother Azita Goshtasebi Approximately 33% of normal-length (21–35 days) cycles have subclinical ovulatory disturbances and lack sufficient progesterone, although their normal length ensures enough estrogen. Subclinical ovulatory disturbances are related to significant premenopausal spine bone loss (−0.86%/year). Molimina, non-distressing premenstrual experiences, may detect ovulation within normal-length cycles. This prospective study assessed the relationship between molimina and ovulation. After 1-cycle of daily diary and first morning urine collections, women answered the Molimina Question (MQ): “Can you tell by the way you feel that your period is coming?” and were invited to share (a) predictive premenstrual experience(s). A 3-fold increase in follicular-luteal pregnanediol levels confirmed ovulation. In 610 spontaneously menstruating women (not on hormonal contraception, mean age 31.5 ± 5.3, menarche age 12.7 ± 1.5, cycle length [CL] 29 days, MQ positive in 89%), reported premenstrual experiences which included negative moods (62%), cramps (48%), bloating (39%), and front (26%) or axillary (25%) breast tenderness. Of 432 women with pregnanediol-documented cycles, 398 (92%) were ovulatory (CL: 29 ± 5) and 34 (8%) had ovulatory disturbances (CL: 32 ± 14). Women with/without ovulatory cycles were similar in parity, body mass index, smoking, dietary restraint and the MQ; ovulatory-disturbed cycles were longer. Molimina did not confirm ovulation. A non-invasive, inexpensive ovulation indicator is needed to prevent osteoporosis.
Jerilynn C. Prior; Chiaki Konishi; Christine L. Hitchcock; Elaine Kingwell; Patti Janssen; Anthony P. Cheung; Nichole Fairbrother; Azita Goshtasebi
MDPI Publishing
1661-7827
16617827
1660-4601
16604601
shingle_catch_all_2 IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women International Journal of Environmental Research and Public Health doi: 10.3390/ijerph15051016 Authors: Jerilynn C. Prior Chiaki Konishi Christine L. Hitchcock Elaine Kingwell Patti Janssen Anthony P. Cheung Nichole Fairbrother Azita Goshtasebi Approximately 33% of normal-length (21–35 days) cycles have subclinical ovulatory disturbances and lack sufficient progesterone, although their normal length ensures enough estrogen. Subclinical ovulatory disturbances are related to significant premenopausal spine bone loss (−0.86%/year). Molimina, non-distressing premenstrual experiences, may detect ovulation within normal-length cycles. This prospective study assessed the relationship between molimina and ovulation. After 1-cycle of daily diary and first morning urine collections, women answered the Molimina Question (MQ): “Can you tell by the way you feel that your period is coming?” and were invited to share (a) predictive premenstrual experience(s). A 3-fold increase in follicular-luteal pregnanediol levels confirmed ovulation. In 610 spontaneously menstruating women (not on hormonal contraception, mean age 31.5 ± 5.3, menarche age 12.7 ± 1.5, cycle length [CL] 29 days, MQ positive in 89%), reported premenstrual experiences which included negative moods (62%), cramps (48%), bloating (39%), and front (26%) or axillary (25%) breast tenderness. Of 432 women with pregnanediol-documented cycles, 398 (92%) were ovulatory (CL: 29 ± 5) and 34 (8%) had ovulatory disturbances (CL: 32 ± 14). Women with/without ovulatory cycles were similar in parity, body mass index, smoking, dietary restraint and the MQ; ovulatory-disturbed cycles were longer. Molimina did not confirm ovulation. A non-invasive, inexpensive ovulation indicator is needed to prevent osteoporosis.
Jerilynn C. Prior; Chiaki Konishi; Christine L. Hitchcock; Elaine Kingwell; Patti Janssen; Anthony P. Cheung; Nichole Fairbrother; Azita Goshtasebi
MDPI Publishing
1661-7827
16617827
1660-4601
16604601
shingle_catch_all_3 IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women International Journal of Environmental Research and Public Health doi: 10.3390/ijerph15051016 Authors: Jerilynn C. Prior Chiaki Konishi Christine L. Hitchcock Elaine Kingwell Patti Janssen Anthony P. Cheung Nichole Fairbrother Azita Goshtasebi Approximately 33% of normal-length (21–35 days) cycles have subclinical ovulatory disturbances and lack sufficient progesterone, although their normal length ensures enough estrogen. Subclinical ovulatory disturbances are related to significant premenopausal spine bone loss (−0.86%/year). Molimina, non-distressing premenstrual experiences, may detect ovulation within normal-length cycles. This prospective study assessed the relationship between molimina and ovulation. After 1-cycle of daily diary and first morning urine collections, women answered the Molimina Question (MQ): “Can you tell by the way you feel that your period is coming?” and were invited to share (a) predictive premenstrual experience(s). A 3-fold increase in follicular-luteal pregnanediol levels confirmed ovulation. In 610 spontaneously menstruating women (not on hormonal contraception, mean age 31.5 ± 5.3, menarche age 12.7 ± 1.5, cycle length [CL] 29 days, MQ positive in 89%), reported premenstrual experiences which included negative moods (62%), cramps (48%), bloating (39%), and front (26%) or axillary (25%) breast tenderness. Of 432 women with pregnanediol-documented cycles, 398 (92%) were ovulatory (CL: 29 ± 5) and 34 (8%) had ovulatory disturbances (CL: 32 ± 14). Women with/without ovulatory cycles were similar in parity, body mass index, smoking, dietary restraint and the MQ; ovulatory-disturbed cycles were longer. Molimina did not confirm ovulation. A non-invasive, inexpensive ovulation indicator is needed to prevent osteoporosis.
Jerilynn C. Prior; Chiaki Konishi; Christine L. Hitchcock; Elaine Kingwell; Patti Janssen; Anthony P. Cheung; Nichole Fairbrother; Azita Goshtasebi
MDPI Publishing
1661-7827
16617827
1660-4601
16604601
shingle_catch_all_4 IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women International Journal of Environmental Research and Public Health doi: 10.3390/ijerph15051016 Authors: Jerilynn C. Prior Chiaki Konishi Christine L. Hitchcock Elaine Kingwell Patti Janssen Anthony P. Cheung Nichole Fairbrother Azita Goshtasebi Approximately 33% of normal-length (21–35 days) cycles have subclinical ovulatory disturbances and lack sufficient progesterone, although their normal length ensures enough estrogen. Subclinical ovulatory disturbances are related to significant premenopausal spine bone loss (−0.86%/year). Molimina, non-distressing premenstrual experiences, may detect ovulation within normal-length cycles. This prospective study assessed the relationship between molimina and ovulation. After 1-cycle of daily diary and first morning urine collections, women answered the Molimina Question (MQ): “Can you tell by the way you feel that your period is coming?” and were invited to share (a) predictive premenstrual experience(s). A 3-fold increase in follicular-luteal pregnanediol levels confirmed ovulation. In 610 spontaneously menstruating women (not on hormonal contraception, mean age 31.5 ± 5.3, menarche age 12.7 ± 1.5, cycle length [CL] 29 days, MQ positive in 89%), reported premenstrual experiences which included negative moods (62%), cramps (48%), bloating (39%), and front (26%) or axillary (25%) breast tenderness. Of 432 women with pregnanediol-documented cycles, 398 (92%) were ovulatory (CL: 29 ± 5) and 34 (8%) had ovulatory disturbances (CL: 32 ± 14). Women with/without ovulatory cycles were similar in parity, body mass index, smoking, dietary restraint and the MQ; ovulatory-disturbed cycles were longer. Molimina did not confirm ovulation. A non-invasive, inexpensive ovulation indicator is needed to prevent osteoporosis.
Jerilynn C. Prior; Chiaki Konishi; Christine L. Hitchcock; Elaine Kingwell; Patti Janssen; Anthony P. Cheung; Nichole Fairbrother; Azita Goshtasebi
MDPI Publishing
1661-7827
16617827
1660-4601
16604601
shingle_title_1 IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
shingle_title_2 IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
shingle_title_3 IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
shingle_title_4 IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
timestamp 2025-06-30T23:34:58.351Z
titel IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
titel_suche IJERPH, Vol. 15, Pages 1016: Does Molimina Indicate Ovulation? Prospective Data in a Hormonally Documented Single-Cycle in Spontaneously Menstruating Women
topic ZP
WW-YZ
uid ipn_articles_6262114